Regulatory status tracker
How tracked peptides are distributed across regulatory categories.
Key takeaways
- Most tracked peptides fall under "research only," meaning they are not approved medicines for any use.
- A peptide can appear in clinical trials without being approved, and trial status does not imply it is safe or effective.
- "Flagged" covers compounds named in regulatory warnings or import alerts, which can change without notice.
Methodology & sources
Each peptide we cover is assigned to exactly one category based on its highest current standing: FDA-approved if it has marketing approval for at least one indication; clinical trials if it has registered, active or completed human trials but no approval; research only if it appears in research without registered human trials; withdrawn if a previously available product was pulled; and flagged if it is named in an FDA warning, import alert, or comparable notice. We check FDA databases and ClinicalTrials.gov monthly and record the date of each status change so the history is auditable. These categories describe legal and regulatory standing only, they are not a judgment of evidence strength, which we assess independently on each peptide page.